Marsha Fanucci is of Syros Pharmaceuticals, Inc.. Currently has a direct ownership of 16,000 shares of SYRS, which is worth approximately $3,200. The most recent transaction as insider was on Jun 05, 2024, when has been sold 4,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16K
0% 3M change
33.33% 12M change
Total Value Held $3,200

Marsha Fanucci Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 05 2024
BUY
Grant, award, or other acquisition
-
4,000 Added 20.0%
16,000 Common Stock
Jun 01 2023
BUY
Grant, award, or other acquisition
-
4,000 Added 25.0%
12,000 Common Stock
Sep 16 2022
BUY
Grant, award, or other acquisition
-
8,000 Added 50.0%
8,000 Common Stock

Also insider at

FMTX
Forma Therapeutics Holdings, Inc. Healthcare
CYCN
Cyclerion Therapeutics, Inc. Healthcare
ALNY
ALNYLAM PHARMACEUTICALS, INC. Healthcare
MF

Marsha Fanucci

Cambridge, MA

Track Institutional and Insider Activities on SYRS

Follow Syros Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SYRS shares.

Notify only if

Insider Trading

Get notified when an Syros Pharmaceuticals, Inc. insider buys or sells SYRS shares.

Notify only if

News

Receive news related to Syros Pharmaceuticals, Inc.

Track Activities on SYRS